Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (311-320 of 443) with videos related to

Pageof 45
Sort By:
American Journal of Hematology|September 18, 2020
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)Monica Poiani, Myriam Labopin, Giorgia Battipaglia, et al.
Bone Marrow Transplantation|January 30, 2021
Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committeeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.
Bone Marrow Transplantation|October 25, 2022
Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMTArnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation|July 3, 2024
Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)Gesine Bug, Myriam Labopin, Alexander Kulagin, et al.
American Journal of Hematology|January 2, 2024
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working PartyNour Moukalled, Myriam Labopin, Jurjen Versluis, et al.
Blood Cancer Journal|February 19, 2024
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trialEolia Brissot, Myriam Labopin, Helene Labussière, et al.
BMC Gastroenterology|June 2, 2019
Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up studyJohn A Snowden, Chris Hawkey, Daniel Hind, et al.
Journal of Hematology & Oncology|September 29, 2023
Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMTArnon Nagler, Myriam Labopin, Didier Blaise, et al.
Experimental Hematology|July 30, 2014
Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adultsAmandine Le Bourgeois, Myriam Labopin, Thierry Guillaume, et al.
American Journal of Hematology|April 26, 2017
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMTJonathan Canaani, Bipin N Savani, Myriam Labopin, et al.
Pageof 45

Showing results (311-320 of 443) with videos related to

Sort By:
Pageof 45
American Journal of Hematology|September 18, 2020
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)Monica Poiani, Myriam Labopin, Giorgia Battipaglia, et al.
Bone Marrow Transplantation|January 30, 2021
Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committeeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.
Bone Marrow Transplantation|October 25, 2022
Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMTArnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation|July 3, 2024
Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)Gesine Bug, Myriam Labopin, Alexander Kulagin, et al.
American Journal of Hematology|January 2, 2024
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working PartyNour Moukalled, Myriam Labopin, Jurjen Versluis, et al.
Blood Cancer Journal|February 19, 2024
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trialEolia Brissot, Myriam Labopin, Helene Labussière, et al.
BMC Gastroenterology|June 2, 2019
Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up studyJohn A Snowden, Chris Hawkey, Daniel Hind, et al.
Journal of Hematology & Oncology|September 29, 2023
Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMTArnon Nagler, Myriam Labopin, Didier Blaise, et al.
Experimental Hematology|July 30, 2014
Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adultsAmandine Le Bourgeois, Myriam Labopin, Thierry Guillaume, et al.
American Journal of Hematology|April 26, 2017
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMTJonathan Canaani, Bipin N Savani, Myriam Labopin, et al.
Pageof 45